Different Types of Imaging Scans: PET/CT Scans
In June 2024, we provided an overview of the different types of imaging scans you may receive if you have MBC. Then we began a deeper dive into each scan,...
Read More PAST ARTICLES
2023
- What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Why Are MBC Outcomes Worse for Black Women Than White Women?
- Leaving a Legacy and Hope: Tissue Donation After Death
- Overcoming Resistance to CDK4/6 Inhibitors
- Researching Ways to Make MBC Treatment Easier to Tolerate
- Meet the Clinical Trial Team: The Institutional Review Board
- The Latest Research on Inflammatory Breast Cancer
- How is ER Low Used in Clinical Trials?
- Artificial Intelligence and MBC: Can AI Improve Detection and Treatment?
- Meet the Clinical Trial Team: The Principal Investigator
- Living Beyond Breast Cancer Conference 2023
- Non-Treatment Trials: Managing Side Effects
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- The Latest Research on Lobular MBC
- Miami Breast Cancer Conference 2023
- Managing Other Health Conditions While Living with MBC
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- Meet the Clinical Trial Team: The Clinical Trial Coordinator
- What are Clinical Practice Guidelines and How are They Developed?
- Who are Clinical Trial Research Team Members?
- What to Know About MBC Treatment-Related Heart Problems
- What are Non-Treatment Trials and Why are They Important?
- Black Wo(Men) Speak Symposium 2022
- What is Stable Disease and How is it Monitored?
- Self-Advocacy: Your Voice in Your Cancer Care
- Clinical Trial Participation: The Patient’s Journey
- Metastatic Trial Search Featured in Clinical Trials Webinar
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
- I Found a Trial I’m Interested In. What’s Next?
- An Overview of Insurance and Clinical Trials
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- Why You Should Consider Repeat Biopsies
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- Breast Cancer Lung Metastasis: Highlighting the Experts
- How To Choose a Cancer Center
2021
2020
2019
SEARCH OUR SITE
for past articles or specific information.